Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective
Open accessThe DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.
Abstract
Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].](https://figures.cochat.ai/paper-figures/5b0f2d6634994ae79cc2c2cbcb3eb075/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-7.jpg)
![Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].](https://figures.cochat.ai/paper-figures/b1ca4ae8602d4e64bbc6cbb3bfa0f28d/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-8.jpg)

![Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].](https://figures.cochat.ai/paper-figures/76d1606acd2449ce8e030af1e4501a72/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-10.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“3D printing enables the fabrication of complex three-dimensional structures via computer-aided design, allows precise control over scaffold porosity, pore size, and microstructure, and facilitates accurate modulation of mechanical strength, and creates microstructures with graded porosity within a single scaffold [88–90].”
From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymers for 3D Printing and Customized Additive Manufacturing
Ligon, S. C., Liska, R., Stampfl, J., Gurr, M., & Mülhaupt, R. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00074 · Cited by 3,741
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Correlation of dynamic and steady flow viscosities
Cox, W. P., & Merz, E. H. (1958) · Journal of Polymer Science · doi:10.1002/pol.1958.1202811812 · Cited by 2,092
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J., & Peppas, N. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.028 · Cited by 1,021
Awaja, F., Gilbert, M., Kelly, G., Fox, B., & Pigram, P. J. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.04.007 · Cited by 928
Three-Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD Model
Sachs, E., Cima, M., & Cornie, J. (1990) · CIRP Annals · doi:10.1016/s0007-8506(07)61035-x · Cited by 871
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Research works printed but not linked: 3
- 107. Hardung H., Djuric D., Ali S. Combining HME & solubilization: Soluplus®—The solid solution. Drug Deliv. Technol. 2010;10:20–27.
- 134. Aho J., Genina N., Edinger M., Botker J.P., Baldursdottir S., Rantanen J. Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study; Proceedings of the 25th Nordic Rheology Conference; Helsinki, Finland. 30 May–1 June 2016; pp. 97–100.
- 164. Campbell R. Pharma to table: 3-D printing and the regulatory future of home remedies. Conn. L. Rev. CONNtemplations. 2017;49:1.
Cited by
Items 201–300 of 355
Anderspuk, H., Viidik, L., Olado, K., Kogermann, K., Juppo, A. M., Heinämäki, J., & Laidmäe, I. (2021) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2021.100031 · Cited by 10
“Rheological properties such as viscosity and viscoelasticity are important material-related factors affecting the 3D printing of liquid and semisolid materials [4,11].”
InfluentialRole of 3D Printing in Pharmaceutical Industry
Arya, R. K. K., Bisht, D., Dhondiyal, K., Kausar, M., Lalhlenmawia, H., Bhutia, P. L., & Kumar, D. (2023) · Contributions to environmental sciences & innovative business technology · doi:10.1007/978-3-031-20443-2_13 · Cited by 11
Miceli, G. C., Martorana, A., Cancilla, F., Pitarresi, G. L., Licciardi, M., & Palumbo, F. S. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c01578 · Cited by 9
Zhao, Q., Liu, C., Chang, Y., Wu, H., Hou, Y., Wu, S., & Guo, M. (2023) · Sensors · doi:10.3390/s23198063 · Cited by 9
“The existing typical 3D printing technologies are material jetting and material extrusion (fused deposition modelling and direct ink writing) [17–22].”
3D printing technology in drug delivery: Polymer properties and applications
Singh, S. K., Kumar, M., Choudhary, D., Chopra, S., & Bhatia, A. (2023) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2023.2289623 · Cited by 13
“[133,173,174] The chemical structures of HPMC, HPMC in powder form, and muco-adhesive oral films of catechin by using HPMC polymer are given in Figure 13(a), (b) and (c).”
Cheng, J. T. Y., Tan, E. C. K., & Kang, L. (2024) · Biofabrication · doi:10.1088/1758-5090/ad837a · Cited by 13
“The ME based system has accounted for over 80% of the research articles on pharmaceutical 3D printing from 2015 to 2019 [39], consisting of SSE, FDM and direct powder extrusion (DPE).”
Jannini, E. A., Vignesh, S. O., & Hassan, T. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2024.2445501 · Cited by 9
“In case of 2D-printing, a substrate, usually an edible carrier is selected upon which an aqueous or non-aqueous drug (ink) is printed in a defined motif [62,63].”
Dhar, S., Ahmad, F., Deshpande, A., Rana, S., Toufeeq Ahmed, A., & Priyadarsini, S. (2025) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-025-06877-4 · Cited by 13
“Extrusion-based bioprinting exhibits remarkable adaptability, allowing for the utilization of inks with diverse viscosities [19].”
Three-Dimensional Printing Technologies in Oral Films Manufacturing—A Minireview
Ozon, E. A., Sârbu, I., Popovici, V., Mitu, M. A., Musuc, A. M., Karampelas, O., & Velescu, B. Ș. (2023) · Processes · doi:10.3390/pr11092628 · Cited by 10
Use of 3D Printing to Support COVID-19 Medical Supply Shortages: A Review
Ishack, S., & Lipner, S. R. (2021) · Journal of 3D Printing in Medicine · doi:10.2217/3dp-2020-0031 · Cited by 11
“FDM uses thermoplastic filaments that pass through multiple heated printer nozzles and can therefore print multiple types of materials simultaneously [9 , 10] .”
BackgroundRony, F. K., Kimbell, G., Serrano, T. R., Clay, D., Ilias, S., & Azad, M. A. (2025) · Micromachines · doi:10.3390/mi16020163 · Cited by 8
“Three-dimensional printing can be used to make custom-designed objects quickly, easily, and affordably [4].”
Self-citationBasak, T., & Shamshina, J. L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060777 · Cited by 9
“In relation to porous chitinous scaffolds, 3D printing includes extrusion-based printing [112].”
BackgroundMeshram, S. I., Hatwar, P. R., Bakal, R. L., & Raut, P. V. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i8.6735 · Cited by 8
Gallo, L., Peña, J. F., Palma, S. D., Real, J. P., & Cotabarren, I. M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122353 · Cited by 10
THREE-DIMENSIONAL PRINTING BY FUSED DEPOSITION MODELING (3DP-FDM) IN PHARMACEUTICS
Ilyés, K. (2020) · FARMACIA · doi:10.31925/farmacia.2020.4.2 · Cited by 8
“years relying on these technologies [9].”
Bom, S., Cavaco, A. M. D. N., Martins, A. M., Ribeiro, H. M., & Marto, J. M. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125760 · Cited by 9
Hachimi, T., Hmazi, F. A., Arhouni, F. E., Zekriti, N., Doghmi, H., & Majid, F. (2026) · Progress in Additive Manufacturing · doi:10.1007/s40964-025-01484-9 · Cited by 10
Expanding the pharmaceutical formulation space in material extrusion 3D printing applications
Prasad, E., ROBERTSON, J. G., Florence, A. J., & Halbert, G. (2023) · Additive manufacturing · doi:10.1016/j.addma.2023.103803 · Cited by 7
“1) in the drive gear [1,7,12 – 20].”
Chitosan‐based spray‐dried solid dispersions of apigenin in a 3D printable drug delivery system
Alali, A. S., Ahmed, M. M., Fatima, F., Anwer, M. K., Ibnauf, M., & Aboudzadeh, M. A. (2024) · Journal of Applied Polymer Science · doi:10.1002/app.56310 · Cited by 7
Direct 3D printing functional surfaces stacked with microstructured filaments
Han, Y., Sun, J., Xu, J., Zhang, Y., Xiao, Q., Jing, H., Chen, B., Kong, X., Cabezudo, N., & Zhang, L. (2023) · Additive manufacturing · doi:10.1016/j.addma.2023.103900 · Cited by 10
Optical tweezer measurements of asymptotic nonlinearities in complex fluids
Gupta, S. K., Lennon, K. R., Joens, M. A., Bandi, H., Galen, M. V., Han, Y., Tang, W., Li, Y., Wasserman, S. C., Swan, J. W., et al. (2021) · Physical review. E · doi:10.1103/physreve.104.064604 · Cited by 7
3D Printing of Pharmaceuticals and Drug Delivery Devices
Lamprou, D. A. (2020) · MDPI eBooks · doi:10.3390/books978-3-03936-424-4 · Cited by 7
Application of PLCL as a biodegradable polymer in biomedical engineering
Zhao, Y., & Liu, H. (2026) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-026-07016-3 · Cited by 7
“…of complex three-dimensional structures via computer-aided design, allows precise control over scaffold porosity, pore size, and microstructure, and facilitates accurate modulation of mechanical strength, and creates microstructures with graded porosity within a single scaffold [88 – 90].”
Brandl, B., Eder, S., Hirtler, A., Khinast, G., Haley, J. C., Schneider, C., Theissl, S., Bramböck, A., Treffer, D. F., Heupl, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73424-6 · Cited by 7
Rony, F. K., Appiah, J., Alawbali, A., Clay, D., Ilias, S., & Azad, M. A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020183 · Cited by 6
“Additionally, the rectilinear, hexagonal, or honeycomb infill pattern affects the printed structure’s mechanical strength (i.e., flexural strength) in 3D printing [10].”
InfluentialSelf-citationPalit, N., Suryavanshi, P., & Banerjee, S. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28973 · Cited by 7
“The dosage precision, along with the release pattern alteration, can be precisely achieved using 3D printing tools in the field of drug delivery (Alomari et al. 2015; Azad et al. 2020; Liaw and Guvendiren 2017; Prasad and Smyth 2016).”
Keerikkadu, M., Chennamsetty, S., Shetty, A., Tippavajhala, V. K., & Rathnanand, M. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100474 · Cited by 6
“…glimepiride, rosuvastatin, and dapagliflozin, used for the treatment of dyslipidemia, hypertension, and diabetes, were successfully loaded into PAM-printed films and tablets, achieving dose uniformity and acceptable release profiles in multiple studies (Azad et al., 2020; Elbadawi et al., 2021).”
Dynamics of stimuli-responsive hydrogel-based nanocarriers in advanced drug delivery systems
Mahmoud, V. L., Kong, Y., Leong, M. Y., & Looi, C. Y. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.101831 · Cited by 10
Research Progress of 3D Printing Technology for Pharmaceutical Preparation
Tang, L., & Xie, B. (2023) · Recent Patents on Engineering · doi:10.2174/1872212118666230306091103 · Cited by 6
3D Printing and Regulatory Considerations
Krishnan, A. V., Lakshman, S. A., & Bhargav, A. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-34119-9_3 · Cited by 9
Enhancing PLA Filament Biocompatibility by Introducing ZnO and Ketoprofen
Neto, T. D. S., Maia, L. S., da Conceição, M. O. T., da Silva, M. B., de Carvalho, L. T., Medeiros, S. F., Faria, M. I. S. D., Migliorini, B. B., de Lima, R., Rosa, D. S., et al. (2024) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-024-03275-1 · Cited by 8
Prasad, E., ROBERTSON, J. G., & Halbert, G. (2024) · Polymers · doi:10.3390/polym16182566 · Cited by 6
“In addition, Soluplus ® failed to form filaments at 30% w / w PCM drug loading when extruded at 140 ◦ C [8,64].”
BackgroundPohjola, J., Soukka, T., Jokinen, M., & Stolt, M. (2025) · CIRP journal of manufacturing science and technology · doi:10.1016/j.cirpj.2025.05.002 · Cited by 5
Kanwal, N., Zhang, M., Law, C., Khan, S., & Huang, J. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107017 · Cited by 2
Khatami, M., Doniavi, A., Allahyari, S., Feizollahi, M., Abazari, A. M., & Fotouhi, M. (2022) · Pharmaceutical Sciences · doi:10.34172/ps.2022.49 · Cited by 6
EXPLORING THE POTENTIAL OF 3D PRINTING IN PHARMACEUTICAL DEVELOPMENT
Kuril, A., Ambekar, A., Nimase, B., Giri, P., Nikam, P., Desai, H., & Aher, S. (2023) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2023v15i6.3085 · Cited by 4
Processing of PLA/PLLA-based composites for medical device applications
Gupta, D., Dogra, V., Verma, D., Chaudhary, A. K., & Tewari, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18915-9.00013-6 · Cited by 5
Svoboda, R. (2024) · Thermochimica Acta · doi:10.1016/j.tca.2024.179790 · Cited by 5
Verma, M., Kumar, J., Pradhan, A. A., Majumder, N., Ghosh, S., & Purwar, R. (2024) · Polymer Engineering and Science · doi:10.1002/pen.26915 · Cited by 5
Yang, K., Liu, Y., Skoog, S. A., & Narayan, R. J. (2024) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-024-01369-7 · Cited by 4
“Additionally, when designing the macromer solutions for 3D printing, one should consider the complex viscosity [42].”
3D-Extrusion Manufacturing of a Kaolinite Dough Taken in Its Pristine State
Boyer, S. A. E., Jandet, L., & Burr, A. (2021) · Frontiers in Materials · doi:10.3389/fmats.2021.582885 · Cited by 5
“Various ranges of applications are concerned, for instance aerospace, electronics, aeronautics, automobile, art, biomedical, healthcare (Azad et al., 2020; Fan et al., 2020), architecture, and building (Shakor et al.”
Background3D PRINTING OF PROLONGED-RELEASE ORAL SOLID DOSAGE FORMS CONTAINING FELODIPINE
Iovanov, R. (2023) · FARMACIA · doi:10.31925/farmacia.2023.3.5 · Cited by 4
Feng, S., & Repka, M. A. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-46015-9_11 · Cited by 5
Wattanawiggan, R., Chansakaow, S., Jantrawut, P., Panraksa, P., Jiaranaikulwanitch, J., Udomsom, S., Worajittiphon, P., & Tipduangta, P. (2024) · Plants · doi:10.3390/plants13162294 · Cited by 4
“Different types of Eudragit ® are available, each designed to control drug release in various formulations [16].”
BackgroundChen, L., Huang, Y., Dai, C., Zhu, L.-Q., Zhao, X., Zhang, K., Fu, X., Yang, W. B., & Yang, M. (2022) · Polymer · doi:10.1016/j.polymer.2022.124692 · Cited by 4
Kok, X. W., Singh, A., & Raimi‐Abraham, B. T. (2022) · Healthcare · doi:10.3390/healthcare10061114 · Cited by 6
“Further work could be conducted using the same designs chosen in this study but with pharmaceutically relevant polymers used in hot-melt extrusion (HME) with demonstrated suitability for FDM 3D printing [31], such as poly(vinyl alcohol) [32].”
MethodChatterjee, P., & Chakraborty, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-8150-9_18 · Cited by 4
Fused Deposition Modeling (FDM) of Pharmaceuticals
Henry, S., Vanhoorne, V., & Vervaet, C. (2023) · Springer eBooks · doi:10.1007/978-981-99-2404-2_2 · Cited by 4
Pebdani, M. H., Sabetvand, R., & Pishkar, I. (2023) · Journal of the Brazilian Society of Mechanical Sciences and Engineering · doi:10.1007/s40430-023-04612-0 · Cited by 4
“Markandan et al. [19] indicated the 3D printing method has enabled rapid prototyping of atomic compounds with short production times and minimal demolition.”
Коshovyi, O., Dolgošev, G., Meegama, U. W., Herodes, K., Hrytsyk, Y., Grytsyk, L., Grytsyk, A. R., Kireyev, I. V., Heinämäki, J., & Raal, A. (2025) · Plants · doi:10.3390/plants14172651 · Cited by 3
“A novel, innovative approach to overcome these challenges is the application of pharmaceutical 3D-printing technologies [41–43], which allow the development of advanced oral dosage forms aimed at improving both the therapeutic efficiency and patient compliance of phytomedicines.”
Menkudale, A. R., Poojary, P. V., Sarkar, S., & Lewis, S. A. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03437-z · Cited by 5
“Polymers such as HPMC, polyethylene oxide (PEO), Soluplus, Kollidon grades, and functional Eudragit polymers must have melt or paste viscosities that allow continuous flow while regaining adequate mechanical strength post-deposition [99, 100].”
Khatibi, A., Khazaei, M., Zamani, S., Jaf, M. A., & Rezakhani, L. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101147 · Cited by 4
“…the continuous extrusion of a pre-gel through a micro-nozzle, providing the unique capability to process high-viscosity materials and high cell densities at ambient temperatures — a feature that is paramount for preserving the sensitive bioactive proteins and growth factors inherent in dECM [36].”
Nanomedicines Obtained by 3D Printing
Funk, N. L., Leão, J., dos Santos, J., de Oliveira, J. V. R., de Andrade, D. F., & Beck, R. C. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-50419-8_13 · Cited by 4
Wang, S., Zhang, F., Li, X., Wu, C., & Fan, G. (2025) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2025.104232 · Cited by 3
Evaluation of the Ability to Accurately Produce Angular Details by 3D Printing of Plastic Parts
Mihalache, A. M., Nagîț, G., Slătineanu, L., Hrițuc, A., Markopoulos, A. P., & Dodun, O. (2021) · Machines · doi:10.3390/machines9080150 · Cited by 3
Panić, J. Č., Todorović, N., Stjepanovic, A. N., & Lalic-Popovic, M. N. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-40155 · Cited by 3
Lacan, F., Johnston, R. E., Carrington, R., Spezi, E., & Theobald, P. S. (2023) · Journal of Medical Engineering & Technology · doi:10.1080/03091902.2023.2193267 · Cited by 3
“Increasing accessibility means that these techniques are being used in more diverse fields, with examples evident in the personalised and precision medicine space including orthopaedics and maxillofacial surgery [1,2], prosthetics and orthotics [3,4], pharmaceutical and cellular [5,6].”
Background3D printing in drug delivery: Current trends and future prospects
Sharma, C., Kabra, A., Thakur, N., & Kaur, B. (2023) · AIP conference proceedings · doi:10.1063/5.0112326 · Cited by 3
Sex-specific formulations of doxazosin mesylate via direct powder extrusion 3D printing
Januskaite, P., Goyanes, Á., Orlu, M., & Basit, A. W. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01862-4 · Cited by 5
The need for fused deposition modeling of composite materials
Sola, A., & Trinchi, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98823-0.00004-4 · Cited by 6
Development of three-dimensional printed biocompatible materials for cartilage replacement
Hashemi, S., Amani, A. M., Abbasi, M., & Golchin, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90597-8.00015-3 · Cited by 5
Extrusion-Based Additive Manufacturing Techniques for Biomedical Applications
Tadayyon, G., Kelly, D. J., & Monaghan, M. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819724-0.00027-6 · Cited by 3
In Silico Predictions Driving the Development of 3D-Printed Drug Delivery Systems
Todke, P. A., Lažauskas, R., & Bernatonienė, J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics18010032 · Cited by 2
“As a result, relying solely on conventional wet-lab approaches for early-stage formulation screening can significantly delay development timelines, increase material consumption, and require repeated optimization cycles before a viable 3D-printed formulation is identified [70,71].”
Engineering Medicines: A Comprehensive Review on 3D Printing in Pharmaceuticals
Das, S., Kumar, A., Jena, R., Singh, N. K., & Harish, V. (2026) · Biomedical Materials & Devices · doi:10.1007/s44174-026-00656-7 · Cited by 2
Nagaraj, A., & Seyfoddin, A. (2026) · Gels · doi:10.3390/gels12050386 · Cited by 2
Padhy, C. P., Suryakumar, S., & Reddy, N. R. (2022) · Lecture notes in mechanical engineering · doi:10.1007/978-981-16-7787-8_13 · Cited by 2
Digital transformation in healthcare
Masoud, R. (2022) · International Journal of Scientific and Research Publications · doi:10.29322/ijsrp.12.07.2022.p12744 · Cited by 5
Renewable Resources for Bio-plastics
(2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013024-00775 · Cited by 2
Synthetic Polymers for HME-Based 3D Printing
Zhou, X., Zhang, C., & Zhang, J. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-46015-9_4 · Cited by 3
Botsula, I., Kireyev, I. V., Коshovyi, O., Heinämäki, J., Raal, A., Mazur, M., & Chebanov, V. A. (2024) · ScienceRise Pharmaceutical Science · doi:10.15587/2519-4852.2024.299205 · Cited by 5
Peña, J. F., Cotabarren, I. M., & Gallo, L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081069 · Cited by 2
“Indeed, several biocompatible polymers have been used to produce filaments, such as ethyl cellulose, polycaprolactone, polylactic acid polyvinylpyrrolidone, and polyvinyl alcohol (PVA) [15,16].”
BackgroundLeverant, A. B., Oprysk, L. M., Dabrowski, A. C., Kyker‐Snowman, K., & Vázquez, M. (2024) · Micromachines · doi:10.3390/mi15091103 · Cited by 2
“The accessibility of 3D printers in public and private maker spaces has revolutionized rapid prototyping to produce a wide range of functional and practical engineering products, as well as personal items, art, toys, and more [26–28].”
BackgroundPolymer microsphere inks for semi-solid extrusion 3D printing at ambient conditions
Pohjola, J., Jokinen, M., Soukka, T., & Stolt, M. (2024) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2024.106783 · Cited by 3
A low-cost, open-source cylindrical Couette rheometer
Erni, M., Hart, A. J., Trumper, D. L., & Owens, C. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-76494-8 · Cited by 2
3D Printing of Cellulose and Chitin from Ionic Liquids for Drug Delivery: A Mini-Review
Shamshina, J. L., & Rogers, R. D. (2021) · Springer eBooks · doi:10.1007/978-981-16-4365-1_5 · Cited by 2
Types of 3D Printers Applied in Industrial Pharmacy and Drug Delivery
Al-Gawhari, F. J., & Al-Zaidi, A. A. M. A. (2022) · Technium BioChemMed · doi:10.47577/biochemmed.v3i2.6064 · Cited by 2
Kawish, S. M., Sharma, S., Almalki, W. H., Alghamdi, S. A., Afzal, O., Kazmi, I. A., Altamimi, A. S. A., Al-Abbasi, F. A., Beg, S., & Ahmad, F. J. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220616123842 · Cited by 3
Recent trends in polymeric composites and blends for three-dimensional printing and bioprinting
Yeleswarapu, S., Vijayasankar, K. N., Chameettachal, S., & Pati, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88524-9.00004-8 · Cited by 2
Aina, M., Baillon, F., Sescousse, R., Sanchez‐Ballester, N. M., Bégu, S., Soulairol, I., & Sauceau, M. (2023) · MATEC Web of Conferences · doi:10.1051/matecconf/202337906002 · Cited by 2
“La connaissance de la gamme de viscosité idéale peut aider à prédire si la formulation de l'hydrogel a des propriétés rhéologiques appropriées pour l'impression 3D [Azad et al., 2020].”
BackgroundEmerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs
Davis, D. A., Thakkar, R., Maniruzzaman, M., Miller, D. A., & Williams, R. O. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88719-3_13 · Cited by 2
Fused deposition modeling of composite materials at a glance – supplementary tables
Sola, A., & Trinchi, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98823-0.00003-2 · Cited by 2
Alali, A. S., Ahmed, M. M., Fatima, F., Anwer, M. K., Ibnauf, M., & Patel, J. (2023) · Preprints.org · doi:10.20944/preprints202304.0470.v1 · Cited by 2
Digital Formulation Development Using 3D Printing Technology: AI and Modeling
Tracy, T. S., Wu, L., Cheng, S., & Li, X. (2024) · doi:10.1002/9781119987260.ch12 · Cited by 2
Ligade, V. S., & Akash, C. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120310 · Cited by 1
“In the pharmaceutical industry, 3DP is a cutting-edge manufacturing technology and it may overcome the traditional manufacturing regime of one-size-fits-all (Azad et al., 2020).”
The use of three-dimensional technologies in the development of oral solid dosage forms
Рубан, О. А., Пуляєв, Д. С., Хохленкова, Н. В., & Іванюк, О. І. (2023) · News of pharmacy · doi:10.24959/nphj.23.112 · Cited by 1
3D printed bespoke solid dosage forms for oral drug delivery
Fatouros, D. G., & Xenikakis, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23645-7.00006-4 · Cited by 1
Panova, N. K., Nikolova, K. T., & Dikova, T. D. (2025) · Archives of Materials Science and Engineering · doi:10.5604/01.3001.0055.2154 · Cited by 1
Dual-extruder 3D-printing of biodegradable subcutaneous implants for controlled drug delivery
Brandl, B., Zeiringer, S., Loidl, L., Palanisamy, A., Heupl, S., Katschnig, M., Nguyen, T. H. L., Roblegg, E., Spoerk, M., & Eder, S. (2025) · Additive manufacturing · doi:10.1016/j.addma.2025.104928 · Cited by 4
Bienhaus, M., Neumann, L., Müller, C., & Runkel, F. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091137 · Cited by 1
“The filaments used as the printing material can be produced by hot melt extrusion (HME) from thermoplastic polymers serving as a carrier material, often combined with other additives, such as plasticisers and fillers, and the desired active ingredient [10].”
Govindan, I., Kailas, A. A., Abutwaibe, K. A., Annadurai, T., Achar, U., Naha, A., & Hebbar, S. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100416 · Cited by 3
“Additionally, 3DP SEDDS must follow the cGMP requirements set by the FDA (Azad et al., 2020).”
InfluentialVyas, J., Raytthatha, N., Gupta, D., Vyas, P., & Prajapati, B. G. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04494-3 · Cited by 1
Uysal, E., Enguven, G., Eğe, H., Deveci, M. Z. Y., Dal, F., Ağtürk, G., Evran, S., Alakuş, İ., Kırgız, Ö., Akçakavak, G., et al. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae4702 · Cited by 1
“In pneumatic 3D printing, the rheological properties of polymers and polymer-active pharmaceutical ingredient (API) mixtures play a crucial role in predicting both the processability of 3D printing and the properties of the final product, such as drug release [39].”
Nagaraj, A., & Seyfoddin, A. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03380-z · Cited by 3
Biomaterial-based approaches for diabetic wound healing
Paculanan, A. A. M. D., Santos, A. M. D., Siapno, X. Y. L., Agueda, J. R. H. S., & Choi, A. E. S. (2026) · Results in Engineering · doi:10.1016/j.rineng.2026.110230 · Cited by 2
de Oliveira, T. V., Leão, A. P., Leão, J., Petzhold, C. L., & Beck, R. C. R. (2026) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.17.30 · Cited by 1
Topical drug delivery systems for breast cancer: emerging roles of nanotechnology and 3D printing
Narula, H., Kamal, R., Dora, C. P., & Dhiman, S. (2026) · Journal of Materials Science · doi:10.1007/s10853-026-13506-0 · Cited by 1
Katakam, P., Jaiswal, H. U., & Adiki, S. K. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127315 · Cited by 1
Recent scenario in pharmaceuticals 3D printing: Multiple techniques and advancements
Varma, A., Satpathy, J., & Sudhakar, K. (2023) · AIP conference proceedings · doi:10.1063/5.0164586 · Cited by 1
3D printing technology in drug delivery
Hamza, D. A. M., & El-sherbiny, I. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00004-7 · Cited by 1
Additive manufacturing of TPU devices for genital herpes treatment with sustained acyclovir release
Rodrigues, V. D. C., Guterres, I. Z., Savi, B. P., Fongaro, G., Silva, I. T., & Salmoria, G. V. (2024) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2024.2396221 · Cited by 1
“The latter is one of the most used and consists of thermal extrusion of polymeric filaments that can be mixed with different sub-stances [5,6].”
Metadata
- Authors
- Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T.
- Affiliations
- North Carolina Agricultural and Technical State University (US)
- Virginia Commonwealth University (US)
- City University of New York (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Azad, Mohammad A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-02-03
- Volume
- 12
- Issue
- 2
- Pages
- 124
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7076526
- OpenAlex
- W3003558240
- Semantic Scholar
- d0e7b174bfd4c9215a0e766bbf1923bb5c15a67d
- Cited by
- 356
- References
- 176
- Citations by year
- 2026: 38 · 2025: 44 · 2024: 48 · 2023: 73 · 2022: 66 · 2021: 57 · 2020: 28
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies
- Physical Sciences › Engineering › Building and Construction › Innovations in Concrete and Construction Materials
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- material extrusion, pharmaceutical 3D printing, fused deposition modeling, polymer rheology, controlled drug release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.